These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34838524)

  • 21. Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings.
    Gareen IF; Black WC; Tosteson TD; Wang Q; Sicks JD; Tosteson ANA
    Med Care; 2018 May; 56(5):403-409. PubMed ID: 29613874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
    National Lung Screening Trial Research Team
    J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
    Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
    Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of the cancer risk management model lung cancer screening module.
    Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
    Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.
    Gohagan J; Marcus P; Fagerstrom R; Pinsky P; Kramer B; Prorok P;
    Chest; 2004 Jul; 126(1):114-21. PubMed ID: 15249451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
    Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
    Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network.
    Petousis P; Han SX; Aberle D; Bui AA
    Artif Intell Med; 2016 Sep; 72():42-55. PubMed ID: 27664507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST).
    Stemmer A; Shadmi R; Bregman-Amitai O; Chettrit D; Blagev D; Orlovsky M; Deutsch L; Elnekave E
    PLoS One; 2020; 15(8):e0236021. PubMed ID: 32745082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest.
    de Torres JP; Bastarrika G; Wisnivesky JP; Alcaide AB; Campo A; Seijo LM; Pueyo JC; Villanueva A; Lozano MD; Montes U; Montuenga L; Zulueta JJ
    Chest; 2007 Dec; 132(6):1932-8. PubMed ID: 18079226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between Incidental Abnormalities on Screening Thoracic Computed Tomography and Mortality: A Long-Term Follow-Up Analysis.
    Lee JE; Jeong WG; Lee HJ; Kim YH; Chae KJ; Jeong YJ
    Korean J Radiol; 2022 Oct; 23(10):998-1008. PubMed ID: 36175001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid Incidentalomas in Association With Low-Dose Computed Tomography in the National Lung Screening Trial.
    Loomans-Kropp HA; Dunn BK; Kramer BS; Pinsky P
    Am J Epidemiol; 2020 Jan; 189(1):27-33. PubMed ID: 31595954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
    Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
    Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchiectasis is associated with lower lung function in lung cancer screening participants.
    Kwee AKAL; Luijk B; de Jong PA; Groen HJM; Aerts JGJV; Charbonnier JP; Vliegenthart R; Mohamed Hoesein FAA
    Eur Radiol; 2024 Jun; 34(6):4155-4162. PubMed ID: 37950082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use and Outcomes of Low-Dose CT Scan Lung Cancer Screening in the Medicare Population.
    Pinsky PF; Miller E
    Chest; 2022 Sep; 162(3):721-729. PubMed ID: 35364090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.
    Tisi S; Creamer AW; Dickson J; Horst C; Quaife S; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Hacker AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; Hurst JR; ; Janes S
    BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37321665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.
    Bonney A; Malouf R; Marchal C; Manners D; Fong KM; Marshall HM; Irving LB; Manser R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013829. PubMed ID: 35921047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
    AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.